Too little and it will be too concentrated, making accurate dosing difficult with standard syringes
Adamchic I, Langguth B, Hauptmann C, Tass PA
Tirzepatide : Targets both GLP-1 and GIP receptors, potentially leading to more significant weight loss and better appetite control
Starting Dose 5 mg subcutaneously, 2-3 times per week This is a moderate pulsed protocol that provides solid AMPK activation without requiring daily injections
From week 21 onwards, if you've plateaued on 2.4mg and are tolerating the medication well, your prescriber may recommend increasing to 7.2mg for enhanced weight loss
Levels of GHK naturally decline as we age and research has demonstrated that this peptide can stimulate synthesis of collagen, elastin, and glycosaminoglycans in the skin